Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19
Coronavirus,Coronavirus Vaccine
A global study of nearly 44,000 found that the COVID-19 vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease.
The study was conducted in the U.S., Latin America and South Africa. The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.
The South African results are troubling because of the coronavirus variant spreading there that has now been detected in the U.S., raising concerns that the vaccines developed so far might not work as well against it.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
United Airlines Resolves Outage After Hundreds of Flight Delays
November 16th, 2026
Headline Roundup
Fewer International Students Enrolled in US Colleges for Second Consecutive Year
November 16th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026